- ￥3900
- biorbyt
- 0.63-40 ng/mL
- 0.231 ng/mL
- orb779628
- 英国
- 2026年01月22日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
999
- 供应商：
biorbyt
- 检测范围：
0.63-40 ng/mL
- 检测方法：
Sandwich
- 应用：
ELISA
- 适应物种：
Rat
- 样本：
Serum, plasma and other biological fluids.
- 灵敏度：
0.231 ng/mL
- 规格：
48 T
产品别名：CD340 ELISA Kit, ErbB2 ELISA Kit, HER-2/neu ELISA Kit, HER2 ELISA Kit, NEU ELISA Kit, MLN 19 ELISA Kit, NGL ELISA Kit, TKR1 ELISA Kit, p185 ELISA Kit, V-Erb-B2 Erythroblastic Leukemia Viral Oncogene Homolog 2 ELISA Kit, Neuro/Glioblastoma Derived Oncogene Homolog ELISA Kit
应用笔记：standard: 40 ng/mL. Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat EGFR2. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat EGFR2. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Rat EGFR2, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat EGFR2 in the samples is then determined by comparing the OD of the samples to the standard curve
实验时长：3.5h
Note：For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Dissecting the Epidermal Growth Factor Receptor Signal Transactivation Pathway
Interreceptor cross-talk has emerged as a general concept in cellular signaling cascades. Therein epidermal growth factor receptor (EGFR) signal transactivation represents the so far best investigated cross-talk mechanism comprising
Silencing Epidermal Growth Factor Receptor by RNA Interference in Glioma
growth factor receptor (EGFR) has been shown to be overexpressed in a variety of tumors and is one of the important mediators responsible for the development of high-grade gliomas, especially in primary glioblastomas. Most recently, RNA interference (RNAi
Soluble Epidermal Growth Factor Receptor Acridinium-Linked Immunosorbent Assay
has been shown to be specific for epidermal growth factor receptor (EGFR) and the isoforms of EGFR encoded by alternate transcripts (i.e., sEGFRs); it, therefore, does not detect other EGFR/ErbB receptor family members, i.e., ErbB2, ErbB3, or ErbB4. In addition
